For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260602:nRSB5304Ga&default-theme=true
RNS Number : 5304G Sabre Insurance Group PLC 02 June 2026
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE MARKET
ABUSE REGULATION (EU NO. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 ("MAR").
2 June 2026
Sabre Insurance Group plc
On-market Share Buyback Programme of £5m
Sabre Insurance Group plc (the "Group", the "Company" or "Sabre"), one of the
UK's leading motor insurance underwriters, announces its intention to launch
an on-market share buyback programme to return £5m to shareholders (the
"Buyback Programme").
Further to the Group's proposal to launch a £5m share buyback programme which
was included in the Group's results announcement in March 2026, the board has
received regulatory approval to proceed. Having reviewed the Group's strong
performance and ongoing capital requirements, the Board has concluded that an
on-market share buyback programme for up to a maximum aggregate consideration
of £5m (excluding stamp duty and expenses) remains appropriate and a
value-enhancing use of cash, while maintaining the Group's financial
flexibility to invest in its strategy. The purpose of this buyback programme
is to return surplus capital to shareholders and reduce the Group's share
capital, whilst maintaining the financial flexibility to invest in the ongoing
execution of our strategy. Accordingly, any ordinary shares purchased are
expected to be cancelled.
Details of the Buyback Programme
Sabre has entered into an irrevocable instruction with Panmure Liberum,
pursuant to which Panmure Liberum will purchase the Company's ordinary shares
of £0.001 each ("Ordinary Shares") for up to a maximum consideration of £5m.
The Buyback Programme will commence immediately and it is anticipated it will
end no later than 31 December 2026, subject to market conditions. The maximum
number of Ordinary Shares that can be purchased (always subject to the
aggregate maximum consideration of £5m (excluding stamp duty and expenses))
is 24,660,000, being the number of shares the Company is authorised to
purchase pursuant to the authority granted by shareholders at the Company's
2026 Annual General Meeting (the "2026 AGM"). Panmure Liberum will make its
trading decisions in relation to the Ordinary Shares independently of, and
uninfluenced by, the Company, within the terms and pre-set parameters of the
Buyback Programme.
Any purchase of Ordinary Shares under the Buyback Programme will take place in
open market transactions and may be made from time to time depending on market
conditions, share price and trading volumes. The Buyback Programme will be
effected under the general authority to repurchase Ordinary Shares granted by
the Company's shareholders at the 2026 AGM, and in accordance with Chapter 12
of the UK Financial Conduct Authority's Listing Rules, and Regulation (EU) No
596/2014 and Commission Delegated Regulation (EU) No 2016/1052 (both as they
form part of UK domestic law by virtue of the European Union (Withdrawal) Act
2018), including where relevant pursuant to the UK Market Abuse Regulation.
Repurchases of Ordinary Shares under the Buyback Programme will be announced
by no later than the end of the seventh daily market session following the
calendar day on which the relevant repurchase occurred. There is no guarantee
that the Buyback will be implemented in full or that any Ordinary Shares will
be repurchased by the Company.
For further information, please contact:
Investor enquiries 01306 747 272
Sabre Insurance Group plc investor.relations@sabre.co.uk (mailto:investor.relations@sabre.co.uk)
Geoff Carter / Adam Westwood
Media enquiries 020 7260 2700
Teneo sabre@teneo.com (mailto:sabre@teneo.com)
James Macey White / Ffion Dash
LEI Code: 2138006RXRQ8P8VKGV98
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END MSCFBMATMTJMBPF
Copyright 2019 Regulatory News Service, all rights reserved